This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
Healio
The U.S. population is growing increasingly diverse, yet that racial and ethnic diversity is not reflected among health care providers.
The gap is particularly pronounced in oncology.
ASCO released a strategic plan designed to promote the development of a culturally competent oncology workforce that is equipped to care for the diverse population of patients with cancer.
READ MORE
NBC News
Advisers to the Food and Drug Administration (FDA) have recommended approval of a new experimental, personalized cancer treatment for children with leukemia. This last-ditch treatment, CAR-T therapy, retrains a patient’s immune system to home in on tumor cells and kill them.
READ MORE
ACS
In this session, How Patient Navigation Drives Quality and Produces Profit in Health Care, Judy Kneece, RN, OCN will discuss patient navigation as an accreditation requirement and as a governmental mandate required by the Affordable Care Act. This session will enable attendees to:
- Describe the need for the development of patient navigation to close gaps and inefficiencies in healthcare care delivery
- Explain why patient navigation impacts quality outcomes for patients and facilities
- Cite clinical studies of how patient navigation programs increased financial profits for facilities and providers by decreasing out-migration and no-show appointments
- Discuss three essential keys for increasing a patient navigation program’s effectiveness and profitability
Don't miss this and other topics being addressed at the 2017 Cancer Programs Conference: Creating a Culture of Quality. This is the only conference developed by the American Joint Committee on Cancer (AJCC), Commission on Cancer (CoC), American College of Surgeons Clinical Research Program (ACS CRP), National Accreditation Program for Breast Centers (NAPBC), and National Cancer Database (NCDB).
Register by this Friday, July 21 to receive the early-bird rate. Need help securing funding to attend the 2017 Cancer Programs Conference? Visit the Justification Toolkit.
|
Promoted by
|
|
|
|
 |
The New York Times
Doctors and medical organizations often advise that past a certain age, older adults can forgo various screening tests for cancer. But many patients, no matter how old or sick they may be, are reluctant to abandon tests they’ve long been told can be lifesaving.
READ MORE
Newsweek
Paul Davies knows what’s wrong with cancer research: Too much cash and too little forethought. Despite billions of dollars invested in fighting this disease, it has remained an inscrutable foe. “There is this assumption that you can solve the problem by throwing money at it,” he says, “that you can spend your way to a solution.” Davies, a theoretical physicist at Arizona State University — and therefore somewhat of an interloper in the field of cancer — claims he has a better idea.
READ MORE
 |
|
Our ihcDirect™ method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our ihcDirect™ product list.
|
|
CoC
The Commission on Cancer (CoC) is looking to identify potential presenters for the 2018 CoC Oncology Lecture at the American College of Surgeons Clinical Congress 2018 on Oct. 21-25, 2018 in Boston. This is one of 11 named lectures that are a part of the Clinical Congress.
The annual Commission on Cancer Oncology Lecture was instituted to focus on current, major developments in oncology and emphasize the role that the surgeon has in caring for patients with cancer. The lecturer should be a recognized leader in the field of oncology who has been involved in clinical and/or laboratory research, and/or cancer management. For 2018, we are seeking experts in one or more of the following areas:
- Cancer immunotherapy
- Palliative care
- Surgical clinical trials in the United States
- Survivorship care
Please click here to suggest up to three names of speakers for 2018. The speakers do not have to be surgeons.
Thank you in advance for assistance. Your response is due by Friday, July 28.
READ MORE
|
Promoted by
|
|
|
|
 |
RTE.ie
A treatment for one of the more hard to treat types of breast cancer could be a step closer thanks to the discovery by Irish based researchers of a potential new therapy.
The scientists have found that a new drug called THZ-1 is capable of halting the growth of triple negative breast cancer.
The researchers say that while use of THZ-1 in humans is still some way off and further study is necessary, the discovery does open up a wider range of new and less toxic treatment options.
READ MORE
Medical Xpress
Cancer cells have an enormous need for oxygen and nutrients. Therefore, growing tumors rely on the simultaneous growth of capillaries, the fine branching blood vessels that form their supply network. The formation of new blood vessels, called angiogenesis, is therefore a possible target for cancer therapy. Physicians use special inhibitors called angiogenesis inhibitors to "starve" tumors. However, these drugs, which have been in use for more than a decade, have limited effectiveness. Deeper understanding of the underlying mechanisms may help identify further therapy targets in order to prevent vessel formation more effectively.
READ MORE
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more.
|
|
ACS-CoC
The American College of Surgeons (ACS) is seeking six Fellows to fill vacancies on the Commission on Cancer (CoC). The initial term of appointment is three years with eligibility for re-election to a second term. Members may hold office or serve as Vice-Chair of a committee or subcommittee during their second term. New members will be recommended by the Nominating Committee, selected in October by the Executive Committee, and then brought before the full CoC membership for approval at the CoC Annual Meeting. The ACS Board of Regents will confirm the final list of new members, and the CoC will announce the new members in late October.
READ MORE
Oncology Nurse Advisor
Ixazomib, a new proteasome inhibitor (PI), is a third option for the treatment of relapsed/refractory multiple myeloma. The new agent offers the potential of improved efficacy and the convenience of oral therapy, according to a report in Therapeutic Advances in Hematology.
Proteasome inhibitors represent the most significant advances in multiple myeloma treatment.
READ MORE
|
|
Your unused cancer medications can save a life. SafeNetRx, the Iowa Cancer Consortium and the Iowa Department of Public Health have partnered to increase the donations of cancer fighting drugs to the Iowa Drug Donation Repository. Learn more about this program and how you can donate to patients in need.
Read more
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Healthcare Finance
Hospital groups oppose a proposed federal rule to cut 340B drug payments, but a group representing oncologists applauds the effort it said will curb the abuse of the discount drug program.
The Centers for Medicare and Medicaid Services has released a proposed rule to cut payment by about 27 percent for certain Medicare Part B drugs purchased through the 340B program. The program is intended to help hospitals that serve a disproportionate number of low-income patients by lowering the cost of drugs.
READ MORE
ACS
Registration is now open for the American College of Surgeons Clinical Congress 2017, Oct. 22–26 in San Diego. Clinical Congress is one of the largest meetings of surgeons in the world and offers outstanding educational opportunities for every stage of your career. The theme of this year's conference is Do What's Right for the Patient.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
